These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38692193)

  • 1. Evaluation of the safety and efficacy of the novel Mycoplasma gallisepticum vaccine, Vaxsafe MG304, after spray-vaccination of 1-day-old specific pathogen-free chicks.
    Kanci Condello A; Wawegama NK; Ekanayake D; Zhu L; Tivendale KA; Shil PK; Daly J; Mohotti S; Todhunter P; Underwood GJ; Noormohammadi AH; Markham PF; Browning GF
    Vet Microbiol; 2024 Jun; 293():110093. PubMed ID: 38692193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of protective immunity induced by Mycoplasma gallisepticum strain ts-304 vaccine in chickens.
    Kanci Condello A; Kulappu Arachchige SN; Shil PK; Underwood GJ; Noormohammadi AH; Markham PF; Wawegama NK; Browning GF
    Vet Microbiol; 2020 Dec; 251():108883. PubMed ID: 33069036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycoplasma gallisepticum strain ts-304 is a safe and effective live attenuated vaccine for use in chickens.
    Kanci Condello A; Underwood GJ; Shil PK; Noormohammadi AH; Markham PF; Wawegama NK; Browning GF
    Vet Microbiol; 2020 May; 244():108654. PubMed ID: 32402331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of administration of tylosin on the duration of protective immunity induced by the novel Mycoplasma gallisepticum vaccine strain, Vaxsafe MG ts-304, in chickens.
    Kanci Condello A; Morrow CJ; Kulappu Arachchige SN; Shil PK; Underwood GJ; Andrews DM; Omotainse OS; Noormohammadi AH; Markham PF; Wawegama NK; Browning GF
    Vet Microbiol; 2023 Jan; 276():109605. PubMed ID: 36455495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the short-term and long-term efficacies of the Mycoplasma gallisepticum vaccines ts-11 and 6/85.
    Noormohammadi AH; Whithear KG
    Avian Pathol; 2019 Jun; 48(3):238-244. PubMed ID: 30773899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunosuppression on the efficacy of vaccination against Mycoplasma gallisepticum infection in chickens.
    Kulappu Arachchige SN; Kanci Condello A; Zhu L; Shil PK; Tivendale KA; Underwood GJ; Noormohammadi AH; Browning GF; Wawegama NK
    Vet Microbiol; 2021 Sep; 260():109182. PubMed ID: 34315003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of a Mycoplasma gallisepticum oppD knockout mutant as a vaccine candidate.
    Tseng CW; Chiu CJ; Kanci A; Noormohammadi AH; Browning GF; Markham PF
    Vaccine; 2017 Oct; 35(45):6248-6253. PubMed ID: 28941621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Response of the Chicken Trachea to Chronic Infection with Virulent Mycoplasma gallisepticum Strain Ap3AS and Vaxsafe MG (Strain ts-304): a Transcriptional Profile.
    Kulappu Arachchige SN; Young ND; Shil PK; Legione AR; Kanci Condello A; Browning GF; Wawegama NK
    Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32122943
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of Mycoplasma gallisepticum (MG) ts-304 vaccine as a live attenuated vaccine in turkeys.
    Kanci A; Wijesurendra DS; Wawegama NK; Underwood GJ; Noormohammadi AH; Markham PF; Browning GF
    Vaccine; 2018 Apr; 36(18):2487-2493. PubMed ID: 29599086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic analysis of the effects of tylosin on the protective immunity provided by the Mycoplasma gallisepticum vaccine Vaxsafe MG ts-304.
    Kamathewatta KI; Kulappu Arachchige SN; Young ND; Condello AK; Wawegama NK; Browning GF
    Vet Microbiol; 2024 Apr; 291():110029. PubMed ID: 38364466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a temperature sensitive mutant Mycoplasma gallisepticum vaccine.
    Whithear KG; Soeripto ; Harrigan KE; Ghiocas E
    Aust Vet J; 1990 May; 67(5):168-74. PubMed ID: 2143068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Mycoplasma gallisepticum vaccine efficacy in a co-infection challenge model with QX-like infectious bronchitis virus.
    Bwala DG; Solomon P; Duncan N; Wandrag DBR; Abolnik C
    Avian Pathol; 2018 Jun; 47(3):261-270. PubMed ID: 29451010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor systemic antibody response after vaccination of commercial broiler breeders with Mycoplasma gallisepticum vaccine ts-11 not associated with susceptibility to challenge.
    Noormohammadi AH; Jones JE; Underwood G; Whithear KG
    Avian Dis; 2002; 46(3):623-8. PubMed ID: 12243526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic Analysis of Long-Term Protective Immunity Induced by Vaccination With
    Kulappu Arachchige SN; Young ND; Kanci Condello A; Omotainse OS; Noormohammadi AH; Wawegama NK; Browning GF
    Front Immunol; 2020; 11():628804. PubMed ID: 33603758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GapA+ Mycoplasma gallisepticum ts-11 has improved vaccine characteristics.
    Shil PK; Kanci A; Browning GF; Marenda MS; Noormohammadi AH; Markham PF
    Microbiology (Reading); 2011 Jun; 157(Pt 6):1740-1749. PubMed ID: 21310786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to vaccination and infection with Mycoplasma gallisepticum in turkeys.
    Wijesurendra DS; Kanci A; Tivendale KA; Devlin JM; Wawegama NK; Bacci B; Noormohammadi AH; Markham PF; Browning GF
    Avian Pathol; 2017 Oct; 46(5):464-473. PubMed ID: 28345962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of infection route and concurrent infectious bronchitis virus vaccination on Mycoplasma gallisepticum disease pathology in an experimental model.
    Leigh SA; Branton SL; Evans JD; Collier SD
    Avian Pathol; 2012 Oct; 41(5):497-503. PubMed ID: 23025670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Layer chicken embryo survival to hatch when administered an in ovo vaccination of strain F Mycoplasma gallisepticum and locations of bacteria prevalence in the newly hatched chick.
    Elliott KEC; Branton SL; Evans JD; Gerard PD; Peebles ED
    Poult Sci; 2017 Sep; 96(11):3879-3884. PubMed ID: 29050407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of Mycoplasma gallisepticum TS-11 vaccine for the protection of layer pullets against challenge with virulent M. gallisepticum R-strain.
    Bíró J; Povazsán J; Korösi L; Glávits R; Hufnagel L; Stipkovits L
    Avian Pathol; 2005 Aug; 34(4):341-7. PubMed ID: 16147571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the effective dose of the live Mycoplasma synoviae vaccine, Vaxsafe MS (strain MS-H) by protection against experimental challenge.
    Jones JF; Whithear KG; Scott PC; Noormohammadi AH
    Avian Dis; 2006 Mar; 50(1):88-91. PubMed ID: 16617988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.